These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 17725455)

  • 41. Diphtheroid peritonitis associated with continuous ambulatory peritoneal dialysis.
    Leung AC; Orange G; Henderson IS; Kennedy AC
    Clin Nephrol; 1984 Oct; 22(4):200-5. PubMed ID: 6509806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
    Sachar M; Shah A
    Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.
    Sethna CB; Bryant K; Munshi R; Warady BA; Richardson T; Lawlor J; Newland JG; Neu A;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1590-1596. PubMed ID: 27340282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
    Rodighiero MP; Dell'Aquila R; Bonello M; Spanò E; Loreto PD; Nalesso F; Ronco C
    Contrib Nephrol; 2007; 154():125-128. PubMed ID: 17099307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.
    Lew SQ; Gruia A
    Perit Dial Int; 2013; 33(1):101-2. PubMed ID: 23349200
    [No Abstract]   [Full Text] [Related]  

  • 46. Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: a single center's experience.
    Szabo T; Siccion Z; Izatt S; Vas SI; Bargman J; Oreopoulos DG
    Adv Perit Dial; 1999; 15():209-12. PubMed ID: 10682104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exit site infections: systematic microbiologic and quality control are needed.
    Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for peritoneal dialysis-related infections.
    Oxton LL; Zimmerman SW; Roecker EB; Wakeen M
    Perit Dial Int; 1994; 14(2):137-44. PubMed ID: 8043666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients.
    Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):89-95. PubMed ID: 2200261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients.
    Piraino B; Bernardini J; Florio T; Fried L
    Perit Dial Int; 2003; 23(5):456-9. PubMed ID: 14604197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amuchina 10% solution, safe antiseptic for preventing infections of exit-site of Tenckhoff catheters, in the pediatric population of a dialysis program.
    Mendoza-Guevara L; Castro-Vazquez F; Aguilar-Kitsu A; Morales-Nava A; Rodriguez-Leyva F; Sanchez-Barbosa JL
    Contrib Nephrol; 2007; 154():139-144. PubMed ID: 17099309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
    Chen SS; Sheth H; Piraino B; Bender F
    Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peritonitis associated with exit site and tunnel infections.
    Gupta B; Bernardini J; Piraino B
    Am J Kidney Dis; 1996 Sep; 28(3):415-9. PubMed ID: 8804241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritoneal dialysis.
    Holley JL; Bernardini J; Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):133-6. PubMed ID: 2382649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. results of a prospective randomized trial.
    Núñez-Moral M; Sánchez-Álvarez E; González-Díaz I; Peláez-Requejo B; Fernández-Viña A; Quintana-Fernández A; Rodríguez-Suárez C
    Perit Dial Int; 2014 May; 34(3):271-7. PubMed ID: 24497599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of povidone iodine in exit site care for patients undergoing continuous peritoneal dialysis (CAPD).
    Wilson AP; Lewis C; O'Sullivan H; Shetty N; Neild GH; Mansell M
    J Hosp Infect; 1997 Apr; 35(4):287-93. PubMed ID: 9152821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Ogg CS; Cameron JS; Poston S; Noble WC
    Perit Dial Int; 1989; 9(1):61-4. PubMed ID: 2488184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.